Panitumumab for Intravenous Infusion 100 mg and 400 mg Special Drug Use Surveillance "Survey on Unresectable, Advanced or Recurrent Colorectal Cancer With Wild-type KRAS Gene" (All-patient Surveillance)
Clinical trial NCT02089737 · COMPLETED
Trial details
- NCT number
- NCT02089737
- Sponsor
- Takeda
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2010-06-01
- Primary completion
- 2012-07-01
- Enrollment
- 3091
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.